Psoriasis Withdrawn Phase 4 Trials for Triamcinolone (DB00620)

Also known as: Psoriasis unspecified / Psoriasis, unspecified

IndicationStatusPhase
DBCOND0013339 (Psoriasis)Withdrawn4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01429870Steroids Added to Dithranol and Narrow Band UVB(Ultraviolet B) (UVBnb) in PsoriasisTreatment